{
    "id": "dbpedia_8105_1",
    "rank": 87,
    "data": {
        "url": "https://ierbs.org/speaker-fiona-cheng/",
        "read_more_link": "",
        "language": "en",
        "title": "AGENDA",
        "top_image": "https://ierbs.org/wp-content/uploads/2019/05/IERBS_Symposium_Speaker_Cheng_300419-1024x426.png",
        "meta_img": "https://ierbs.org/wp-content/uploads/2019/05/IERBS_Symposium_Speaker_Cheng_300419-1024x426.png",
        "images": [
            "https://ierbs.org/wp-content/uploads/2022/02/IERBS-Logo-light_2022.02.25_v01.png",
            "https://ierbs.org/wp-content/uploads/2022/02/IERBS-Logo-light_2022.02.25_v01.png",
            "https://ierbs.org/wp-content/uploads/2019/02/07_Fiona-Cheng_name_02.png",
            "https://ierbs.org/wp-content/uploads/2019/05/IERBS_Symposium_Speaker_Cheng_300419.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2020-08-05T23:30:12+08:00",
        "summary": "",
        "meta_description": "[fusion_builder_container hundred_percent=”no&#82 […]",
        "meta_lang": "zh",
        "meta_favicon": "https://ierbs.org/wp-content/uploads/2022/03/cropped-logo_工作區域-1-e1646807430589-1-32x32.png",
        "meta_site_name": "IERBS Org",
        "canonical_link": "https://ierbs.org/speaker-fiona-cheng/",
        "text": "CURRENT POSITION:\n\nChief of Department of General Surgery ,Shin Kong Wu Ho-Su Memorial Hospital\n\nDirector of Breast Cancer Center, Shin Kong Wu Ho-Su Memorial Hospital\n\nVice President,Taiwan Oncoplastic Breast Surgery Society\n\nEDUCATION:\n\nMaster of Science , National Taiwan University Graduate Institute of Forensic Medicine\n\nMedical Degree, China Medical University , Taiwan\n\nSPECIALTY:\n\nBreast Specialist ( Surgeon)\n\nSurgical Specialist ( General & Gastroenterol sugery)\n\nCancer Palliative Medicine\n\nHONORS / AWARDS:\n\n2013 Best Paper reward From Taiwan Breast Cancer Society.\n\nSELECTED PUBLICATIONS :\n\nExpression of the serine protease, matriptase, in breast ductal carcinom\n\nOf Chinese women: Correlation with clinicopathological parameters.\n\nJ.S.Jin, T.F.Cheng .W.C.Tsai, L.F.Sheu, H.Chiang, C.p.Yu.Histopathol.2007; 22:305-309.\n\n.Metronomic Therapy for Metastatic Breast Cancer: A Preliminary Report. Fiona Tsui-Fen Cheng, Yenn-Hwei Chou, Yen-Kung Chen,Sheng-Chuan His. Formos J Surg 2007; 40(2):75-80\n\n.First-line Therapy with Lapatinib ( Tykerb) in Metastatic Breast Cancer that Progressed on Adjuvant Trastuzumab (Herceptin) Treatment: report of a case\n\nYa-Fen Hsu, Fiona Tsui-Fen Cheng, Yen-Kung Chen, Chin-Chu Wu. Formos J Surg 2010; 43:47-52\n\n.The Residual of Radiotracer Activity from Sentinel Lymph Scan Affects Imaging Interpretation of the whole Body Bone Scan.\n\nYen-Chyi Chen, Chi-Tai Ku, Tsui-Fen Cheng, Yen-Kung chen. J Nucl Med Tech 2010; 7:7-10\n\n.Outcome of Fulvestrant in Pretreated Metastatic Breast Cancer Patients in a Medical Center in Taiwan\n\nFiona Tsui-Fen Cheng , Yang-Kong Chen. J. Cancer Res,Pract.27(1),10-18,2012\n\n.Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer\n\nTsui Fen Cheng ,Jung Der Wang ,Wu Ching Uen\n\nBMC Cancer 2012, 12:33 doi:10.1186/1471-2407-12-33\n\nCancer risk in patients with Hashimoto’s thyroiditis: a nationwide cohort study.\n\nYen-Kung Chen, Fiona Tsui-Fen Cheng , Fung-Chang Sung, Chia-Hung Kao\n\nBRITISH JOURNAL OF CANCER，2013 oct，109(9):2496-2501\n\nEvaluation the Availability of Cancer Tissue in Human Identity: Mutations of 15 STR Loci from Breast Cancer Tissue\n\nFiona Tsui -Fen Cheng, Yuh-Yu Chao, Chia-Tung Shun, James Chun-I Lee\n\nThe Taiwan J. of Forensic Med, 5. (2), 2013, 32 – 43\n\nCardio toxicity Associated with Trastuzumab Therapy in Taiwan: A Single Medical Center’s 5-Year Experience\n\nChe-Ming Chang, Fiona Tsui-Fen Cheng ,Tsen-Long Yang, Wu-Chin Wen\n\nJ. Cancer Res. Pract. 2(2), 139-150, 2015\n\nPatient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide\n\nJungsil Ro, Fiona Tsui-Fen Cheng,1 Virote Sriuranpong,2 Antonio Villalon,3 B. K Smruti,4 Janice Tsang,5 Yoon Sim Yap,6 and Asian Working Group for Eribulin Clinical Guide\n\nJ Breast Cancer. 2016 Mar; 19(1):8-17.\n\nMultiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer\n\nPo-Han Lin1,2, Wen-Hung Kuo3, Ai-Chu Huang2, Yen-Shen Lu4, Ching-Hung Lin4, Sung-Hsin Kuo4, Ming-Yang Wang3, Chun-Yu Liu6, Fiona Tsui-Fen Cheng7, Ming-Hsin Yeh8, Huei-Ying Li2, Yu-Hsuan Yang2, Yu-Hua Hsu2, Sheng-Chih Fan2, Long-Yuan Li9, Sung-Liang Yu10, King-Jen Chang11, Pei-Lung Chen2, Yen-Hsuan Ni2,5, Chiun-Sheng Huang3\n\nOncotarget. 2016; 7:8310-8320.\n\nPazopanib Sensitivity in a Patient with Breast Cancer and FGFR1 Amplification\n\nFiona Tsui-Fen Cheng, Fu Ou-Yang, Nina Lapke, Kai-Che Tung, Yen-Kung, Yuh-Yu Chou, Chen, and Shu-Jen Chen\n\nJ Natl Compr Canc Netw 2017;15:1456-1459;\n\nMulti-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan.\n\nLai HW1,2,3, Liu LC4,5, Ouyang F6,7,8, Yao CC9,10, Jan HC11, Chang YH11, Tu CW12, Chen DR2,10, Cheng TF13, Tzeng YD14, Hsu HM15, Yeh MH9,10, Wu YC4,5, Yang PS16,17, Lam HB16,17, Hou MF7,8,18, Chen FM6,7,8.\n\nPLoS One. 2017; 12(11): e0185876."
    }
}